Neubase Therapeutics Inc. buy elfe
Start price
31.01.15
/
50%
€2,596.8
Target price
01.06.15
€4,800.0
Performance (%)
-64.20%
End price
01.06.15
€929.60
Summary
This prediction ended on 01.06.15 with a price of €929.60. The BUY prediction by elfe for Neubase Therapeutics Inc. performed very badly with a performance of -64.20%. elfe has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Neubase Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | 2,99 % | 3,22 % | 4,27 % | 53,70 % |
| iShares Nasdaq 100 | -1,58 % | -3,17 % | 24,75 % | 76,70 % |
| iShares Nikkei 225® | -2,25 % | -9,92 % | 43,52 % | 60,79 % |
| iShares S&P 500 | -0,01 % | 1,64 % | 20,97 % | 62,81 % |
Comments by elfe for this prediction
In the thread NeuBase Therapeutics Inc. diskutieren
Neue Wege und klare Lösungen, Ohr Pharmaceutical auf dem weg neuartige Therapien zu finden.
Marktplazierung: 172,85 Millionen Euro
Anzahl der Aktien: 25,39 Millionen
Kaufsignal
(Vom Mitglied beendet)